{"id":28655,"date":"2025-03-04T15:50:27","date_gmt":"2025-03-04T07:50:27","guid":{"rendered":"https:\/\/flcube.com\/?p=28655"},"modified":"2025-03-04T15:50:30","modified_gmt":"2025-03-04T07:50:30","slug":"shanghai-bioscience-completes-rmb-100m-financing-round-led-by-huagai-capital","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=28655","title":{"rendered":"Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital"},"content":{"rendered":"\n<p>China-based Shanghai BioScience Co., Ltd., a life sciences service platform, announced the completion of a new financing round, raising RMB 100 million (USD 13.73 million). The funding round was solely led by HUAGAI Capital. The proceeds will be used to accelerate the construction of independent brand product lines through mergers and acquisitions and independent development, build a modern supply chain system, strengthen the construction of digital e-commerce platforms, and comprehensively enhance the ability to serve global customers.<\/p>\n\n\n\n<p><strong>Company Background<\/strong><br>Founded in 2005, BioScience has established partnerships with a number of high-profile companies, including Danaher, Thermo Fisher, and others. The company has been committed to providing comprehensive life sciences services and has continuously expanded its business scope and service capabilities.<\/p>\n\n\n\n<p><strong>Future Plans<\/strong><br>With the support of this new round of financing, BioScience plans to further expand its product lines and enhance its supply chain management capabilities. The company will also focus on strengthening its digital e-commerce platform to better serve its global customer base. The funding will play a crucial role in supporting BioScience&#8217;s strategic development and market expansion.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>China-based Shanghai BioScience Co., Ltd., a life sciences service platform, announced the completion of a&#8230;<\/p>\n","protected":false},"author":1,"featured_media":28657,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[535,3806,523],"class_list":["post-28655","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-danaher","tag-shanghai-bioscience","tag-thermo-fisher-scientific"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"China-based Shanghai BioScience Co., Ltd., a life sciences service platform, announced the completion of a new financing round, raising RMB 100 million (USD 13.73 million). The funding round was solely led by HUAGAI Capital. The proceeds will be used to accelerate the construction of independent brand product lines through mergers and acquisitions and independent development, build a modern supply chain system, strengthen the construction of digital e-commerce platforms, and comprehensively enhance the ability to serve global customers.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=28655\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital\" \/>\n<meta property=\"og:description\" content=\"China-based Shanghai BioScience Co., Ltd., a life sciences service platform, announced the completion of a new financing round, raising RMB 100 million (USD 13.73 million). The funding round was solely led by HUAGAI Capital. The proceeds will be used to accelerate the construction of independent brand product lines through mergers and acquisitions and independent development, build a modern supply chain system, strengthen the construction of digital e-commerce platforms, and comprehensively enhance the ability to serve global customers.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=28655\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-04T07:50:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-03-04T07:50:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0409-png.avif\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28655#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28655\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital\",\"datePublished\":\"2025-03-04T07:50:27+00:00\",\"dateModified\":\"2025-03-04T07:50:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28655\"},\"wordCount\":191,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28655#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0409-png.avif\",\"keywords\":[\"Danaher\",\"Shanghai BioScience\",\"Thermo Fisher Scientific\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=28655#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28655\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=28655\",\"name\":\"Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28655#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28655#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0409-png.avif\",\"datePublished\":\"2025-03-04T07:50:27+00:00\",\"dateModified\":\"2025-03-04T07:50:30+00:00\",\"description\":\"China-based Shanghai BioScience Co., Ltd., a life sciences service platform, announced the completion of a new financing round, raising RMB 100 million (USD 13.73 million). The funding round was solely led by HUAGAI Capital. The proceeds will be used to accelerate the construction of independent brand product lines through mergers and acquisitions and independent development, build a modern supply chain system, strengthen the construction of digital e-commerce platforms, and comprehensively enhance the ability to serve global customers.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28655#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=28655\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28655#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0409-png.avif\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/0409-png.avif\",\"width\":1080,\"height\":608,\"caption\":\"Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=28655#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital - Insight, China&#039;s Pharmaceutical Industry","description":"China-based Shanghai BioScience Co., Ltd., a life sciences service platform, announced the completion of a new financing round, raising RMB 100 million (USD 13.73 million). The funding round was solely led by HUAGAI Capital. The proceeds will be used to accelerate the construction of independent brand product lines through mergers and acquisitions and independent development, build a modern supply chain system, strengthen the construction of digital e-commerce platforms, and comprehensively enhance the ability to serve global customers.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=28655","og_locale":"en_US","og_type":"article","og_title":"Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital","og_description":"China-based Shanghai BioScience Co., Ltd., a life sciences service platform, announced the completion of a new financing round, raising RMB 100 million (USD 13.73 million). The funding round was solely led by HUAGAI Capital. The proceeds will be used to accelerate the construction of independent brand product lines through mergers and acquisitions and independent development, build a modern supply chain system, strengthen the construction of digital e-commerce platforms, and comprehensively enhance the ability to serve global customers.","og_url":"https:\/\/flcube.com\/?p=28655","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-03-04T07:50:27+00:00","article_modified_time":"2025-03-04T07:50:30+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0409-png.avif","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=28655#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=28655"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital","datePublished":"2025-03-04T07:50:27+00:00","dateModified":"2025-03-04T07:50:30+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=28655"},"wordCount":191,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=28655#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0409-png.avif","keywords":["Danaher","Shanghai BioScience","Thermo Fisher Scientific"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=28655#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=28655","url":"https:\/\/flcube.com\/?p=28655","name":"Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=28655#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=28655#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0409-png.avif","datePublished":"2025-03-04T07:50:27+00:00","dateModified":"2025-03-04T07:50:30+00:00","description":"China-based Shanghai BioScience Co., Ltd., a life sciences service platform, announced the completion of a new financing round, raising RMB 100 million (USD 13.73 million). The funding round was solely led by HUAGAI Capital. The proceeds will be used to accelerate the construction of independent brand product lines through mergers and acquisitions and independent development, build a modern supply chain system, strengthen the construction of digital e-commerce platforms, and comprehensively enhance the ability to serve global customers.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=28655#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=28655"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=28655#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0409-png.avif","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0409-png.avif","width":1080,"height":608,"caption":"Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=28655#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"Shanghai BioScience Completes RMB 100M Financing Round Led by HUAGAI Capital"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/03\/0409-png.avif","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=28655"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28655\/revisions"}],"predecessor-version":[{"id":28658,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/28655\/revisions\/28658"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/28657"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=28655"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=28655"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=28655"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}